Neurotech International Ltd Net Assets

Latest as of June 2026: AU$611.14K AUD ≈ $432.42K USD

Neurotech International Ltd net assets. Based on the latest financial reports, Neurotech International Ltd (NTI) has net assets worth AU$611.14K AUD (≈ $432.42K USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$2.75 Million ≈ $1.94 Million USD) and total liabilities (AU$2.14 Million ≈ $1.51 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore NTI year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$611.14K
% of Total Assets	22.24%
Annual Growth Rate	-6.9%
5-Year Change	-57.26%
10-Year Change	-85.77%
Growth Volatility	345.03

Net Assets of Neurotech International Ltd (2015–2026)

Net assets of Neurotech International Ltd from 2015 to 2026. This chart illustrates how Neurotech International Ltd's net assets have evolved over time, based on quarterly financial data. See NTI equity to assets ratio to measure how much of total assets are equity-financed.

Annual Net Assets for Neurotech International Ltd (2015–2026)

The table below shows the annual net assets of Neurotech International Ltd from 2015 to 2026. For live market cap and overall valuation, see Neurotech International Ltd market capitalisation.

Year	Net Assets	Change
2026-06-30	AU$611.14K ≈ $432.42K	-79.32%
2025-06-30	AU$2.95 Million ≈ $2.09 Million	-75.17%
2024-06-30	AU$11.90 Million ≈ $8.42 Million	+200.32%
2023-06-30	AU$3.96 Million ≈ $2.80 Million	+177.06%
2022-06-30	AU$1.43 Million ≈ $1.01 Million	-62.97%
2021-06-30	AU$3.86 Million ≈ $2.73 Million	+697.48%
2020-06-30	AU$-646.29K ≈ $-457.29K	-317.30%
2019-06-30	AU$297.41K ≈ $210.44K	-92.97%
2018-06-30	AU$4.23 Million ≈ $2.99 Million	-1.49%
2017-06-30	AU$4.30 Million ≈ $3.04 Million	-70.34%
2016-06-30	AU$14.48 Million ≈ $10.25 Million	+1018.47%
2015-12-31	AU$1.29 Million ≈ $916.07K	--

Equity Component Analysis

This analysis shows how different components contribute to Neurotech International Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5751928800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Neurotech International Ltd Net Assets Breakdown (June 2026)

Neurotech International Ltd net assets breakdown by equity component as of June 2026.

Component	Amount	Percentage
Common Stock	AU$52.49 Million	8589.51%
Other Comprehensive Income	AU$6.81 Million	1114.60%
Other Components	AU$1.00	0.00%
Total Equity	AU$611.14K	100.00%

Neurotech International Ltd Competitors by Market Cap

The table below lists competitors of Neurotech International Ltd ranked by their market capitalization.

Company	Market Cap
Mgenplus Co. Ltd. KQ:032790	$18.31 Million
Lyckegard Group AB ST:LYGRD	$18.31 Million
Birko Birlesik Koyunlulular Mensucat Ticaret ve Sanayi AS IS:BRKO	$18.31 Million
Rathbone Brothers PLC LSE:RAT	$18.32 Million
IXUP Ltd AU:IXU	$18.29 Million
BOXABL Inc. NASDAQ:BXBL	$18.28 Million
Gold Strike Resources Corp. V:GSR	$18.28 Million
Rectitude Holdings Ltd Ordinary Shares NASDAQ:RECT	$18.27 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Neurotech International Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 2,954,549 to 611,141, a change of -2,343,408 (-79.3%).
Net loss of 6,538,516 reduced equity.
Other comprehensive income increased equity by 615,446.
Other factors increased equity by 3,579,662.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	AU$-6.54 Million	-1069.89%
Other Comprehensive Income	AU$615.45K	+100.7%
Other Changes	AU$3.58 Million	+585.73%
Total Change	AU$-	-79.32%

Book Value vs Market Value Analysis

This analysis compares Neurotech International Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 30.95x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 0.14x to 30.95x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-06-30	AU$0.11	AU$0.02	x
2017-06-30	AU$0.06	AU$0.02	x
2018-06-30	AU$0.04	AU$0.02	x
2019-06-30	AU$0.00	AU$0.02	x
2020-06-30	AU$0.00	AU$0.02	x
2021-06-30	AU$0.01	AU$0.02	x
2022-06-30	AU$0.00	AU$0.02	x
2023-06-30	AU$0.00	AU$0.02	x
2024-06-30	AU$0.01	AU$0.02	x
2025-06-30	AU$0.00	AU$0.02	x
2026-06-30	AU$0.00	AU$0.02	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Neurotech International Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -1069.89%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 0.00%
• Asset Turnover: 0.00x
• Equity Multiplier: 4.50x
Recent ROE (-1069.89%) is below the historical average (-332.67%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	-64.84%	-390.01%	0.07x	2.54x	AU$-968.88K
2016	-28.95%	-1722.11%	0.01x	2.04x	AU$-2.93 Million
2017	-93.87%	-4565.50%	0.02x	1.15x	AU$-4.46 Million
2018	-94.31%	-13280.17%	0.01x	1.09x	AU$-4.41 Million
2019	-1614.66%	-2468.29%	0.30x	2.19x	AU$-4.83 Million
2020	0.00%	-2214.72%	0.96x	0.00x	AU$-1.65 Million
2021	-192.43%	-3604.58%	0.04x	1.30x	AU$-7.82 Million
2022	-235.12%	-8787.42%	0.02x	1.41x	AU$-3.51 Million
2023	-196.67%	-130759.17%	0.00x	1.34x	AU$-8.19 Million
2024	-42.60%	-258239.99%	0.00x	1.03x	AU$-6.26 Million
2025	-358.73%	-433.60%	0.75x	1.10x	AU$-10.89 Million
2026	-1069.89%	0.00%	0.00x	4.50x	AU$-6.60 Million

Industry Comparison

This section compares Neurotech International Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $11,206,087
Average return on equity (ROE) among peers: -128.77%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Neurotech International Ltd (NTI)	AU$611.14K	-64.84%	3.50x	$18.30 Million
Adalta Ltd (1AD)	$7.49 Million	-79.00%	0.24x	$5.41 Million
Algorae Pharmaceuticals Ltd (1AI)	$4.14 Million	-76.87%	0.39x	$12.88 Million
ACRUX Ltd (ACR)	$11.28 Million	0.00%	0.07x	$2.61 Million
Actinogen Medical Ltd (ACW)	$346.99K	-440.69%	0.34x	$92.21 Million
Argenica Therapeutics Ltd (AGN)	$7.67 Million	-62.81%	0.24x	$8.63 Million
Arovella Therapeutics Ltd (ALA)	$3.77 Million	-28.27%	0.24x	$42.76 Million
Anatara Lifesciences Ltd (ANR)	$535.97K	-364.70%	1.14x	$1.40 Million
Alterity Therapeutics Ltd (ATH)	$16.68 Million	-32.69%	0.05x	$108.75 Million
Amplia Therapeutics Ltd (ATX)	$8.61 Million	-25.79%	0.06x	$32.32 Million
Avecho Biotechnology Ltd (AVE)	$51.55 Million	-176.92%	0.34x	$32.81 Million

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$18.30 Million

AU$25.86 Million AUD

Market Cap Rank

#25215 Global

#1050 in Australia

Share Price

AU$0.02

Change (1 day)

-5.88%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.48